Pothina Tejasri and Mukthinuthalapati Mathrusri Annapurna

Department of Pharmaceutical Analysis, GITAM School of Pharmacy, GITAM (Deemed to be) University, Visakhapatnam, Andhra Pradesh, India

*Corresponding Author: Mukthinuthalapati Mathrusri Annapurna, Department of Pharmaceutical Analysis, GITAM School of Pharmacy, GITAM (Deemed to be) University, Visakhapatnam, Andhra Pradesh, India.

Received: November 17, 2023; Published: November 28, 2023

Abstract

Ezetimibe is a lipid-lowering compound that inhibits intestinal cholesterol and phytosterol absorption. It belongs to a group of selective and very effective 2-azetidione cholesterol absorption inhibitors. A brief review of the analytical techniques such as spectrophotometry, liquid chromatography, mass spectrometry so far developed for the estimation of Ezetimibe were summarized in the present study.

Keywords: Ezetimibe; Cholesterol; Methanol; Ethanol

References

1. Sudhop T and Von Bergmann K. “Cholesterol absorption inhibitors for the treatment of hypercholesterolemia”. Drugs  62(2002): 2333-2347.v
2. Patrick JE., et al. “Disposition of the selective cholesterol absorption inhibitor Ezetimibe in healthy male subjects”. Drug Metabolism and Disposition 30(2002): 430-437.
3. Kosoglou T., et al. “Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions”. Clinical Pharmacokinetics 5(2005): 467-494.
4. Metreyi Sharma., et al. “UV and three derivative spectrophotometric methods for determination of Ezetimibe in tablet formulation”. Indian Journal of Pharmaceutical Sciences 2 (2008): 258-260.
5. Baby Sudha Lakshmi P., et al. “Spectrophotometric determination of Ezetimibe”. E-Journal of Chemistry 2 (2010): 101-104.
6. Kabra RP., et al. “Simple novel UV-spectroscopic method for estimation of Ezetimibe in tablet dosage form”. American Journal of Pharmacy Health Research9 (2014): 65-71.
7. Ramakrishna “New simple and economical spectrophotometric methods for estimation of Ezetimibe in bulk drug and pharmaceutical dosage forms”. Asian Journal of Research in Chemistry 4.2(2011): 250-253.
8. Avinash MB., et al. “Development and validation of novel UV spectroscopic assay method of ezetimibe in bulk drugs and drug formulations”. World Journal of Pharmaceutical Research4 (2017): 505-517.
9. Sistla R., et al. “Development and validation of a reversed-phase HPLC method for the determination of Ezetimibe in pharmaceutical dosage forms”. Journal of Pharmaceutical and Biomedical Analysis3-4 (2005): 517-522.
10. Saranjit Singh., et al. “Stress degradation studies on Ezetimibe and development of a validated stability-indicating HPLC assay”. Journal of Pharmaceutical and Biomedical Analysis 41 (2006):1037-1040.
11. Zhiqiang Luo., et al. “Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in Ezetimibe drug substance and drug product”. Talanta 139 (2015): 67-74.
12. Anuradha KG and Vishal DS. “Isolation and structure elucidation of major alkaline degradant of Ezetimibe”. Journal of Pharmaceutical and Biomedical Analysis 55 (2011): 225-229.
13. Praveen Kumar., et al. “A stability indicating RP-HPLC method development for determination of Ezetimibe in tablet dosage form”. Der Pharma Chemica3 (2012):1296-1304.
14. Baokar SB., et al. “Analytical Method Development and Validation for Estimation of Ezetimibe from Tablet Dosage Form by Using RP-HPLC”. International Journal of Research in Pharmaceutical and Biomedical Sciences2 (2011): 833-841.
15. Akmar SK., al. “Reverse phase high performance liquid chromatography method for estimation of Ezetimibe in bulk and pharmaceutical formulations”. Indian Journal of Pharmaceutical Sciences5 (2007): 695-697.
16. Hossein Danafar. “High performance liquid chromatographic method for determination of Ezetimibe in pharmaceutical formulation tablets”. Pharmaceutical and Biomedical Research 3 (2016): 38-46.
17. Pandey S and Rathanand“Development and validation of stability indicating reversed-phase HPLC method for the determination of Ezetimibe in pharmaceutical dosage forms”. International Journal of Pharmaceutical Sciences 1.1(2010): 53-57.
18. Hanshyam Panjwani., et al. “Development and validation of a new reversed-phase HPLC method for the determination of Ezetimibe in pharmaceutical dosage forms”. Indian Journal of Pharmaceutical Education and Research1 (2013): 7-12.
19. Hossein Danafar., et al. “A rapid and sensitive LC-MS method for determination of Ezetimibe concentration in human plasma: application to a bioequivalence study”. Chromatographia 76(2013):1667-1675.
20. Oliveira PR., et al. “Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of Ezetimibe in human plasma and pharmaceutical formulations”. Chromatographia7/8 (2006): 315-320.
21. Nuran Özaltin., et al. “Quantitative analysis of Ezetimibe in human plasma by gas chromatography-mass spectrometry”. Journal of Separation sciences 32 (2009): 1868-1874.
22. Shuijun Li., et al. “Liquid chromatography-negative ion electrospray tandem mass spectrometry method for the quantification of Ezetimibe in human plasma”. Journal of Pharmaceutical and Biomedical Analysis 40 (2006): 987-992.

Citation

Citation: Pothina Tejasri and Mukthinuthalapati Mathrusri Annapurna. “A Review on Analytical Techniques for the Assay of Ezetimibe".Acta Scientific Pharmaceutical Sciences 7.12 (2023): 63-66.

Copyright

Copyright: © 2023 Pothina Tejasri and Mukthinuthalapati Mathrusri Annapurna. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.